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Introduction:Magnetic resonance imaging (MRI) has become key in the diagnosis and disease monitoring of pa-
tients withmultiple sclerosis (MS). Both, T2 lesion load and Gadolinium (Gd) enhancing T1 lesions represent im-
portant endpoints in MS clinical trials by serving as a surrogate of clinical disease activity. T2- and ﬂuid-
attenuated inversion recovery (FLAIR) lesion quantiﬁcation - largely due to methodological constraints – is still
being performedmanually or in a semi-automated fashion, although strong efforts have beenmade to allow au-
tomated quantitative lesion segmentation. In 2012, Schmidt and co-workers published an algorithm to be ap-
plied on FLAIR sequences. The aim of this study was to apply the Schmidt algorithm on an independent data
set and compare automated segmentation to inter-rater variability of three independent, experienced raters.
Methods:MRI data of 50 patients with RRMSwere randomly selected from a larger pool of MS patients attending
theMSClinic at theBrain andMindCentre, University of Sydney, Australia.MRIswere acquired on a 3.0T GE scan-
ner (Discovery MR750, GE Medical Systems, Milwaukee, WI) using an 8 channel head coil. We determined T2-
lesion load (total lesion volume and total lesion number) using three versions of an automated segmentation al-
gorithm (Lesion growth algorithm (LGA) based on SPM8 or SPM12 and lesion prediction algorithm (LPA) based
on SPM12) as ﬁrst described by Schmidt et al. (2012). Additionally, manual segmentation was performed by
three independent raters. We calculated inter-rater correlation coefﬁcients (ICC) and dice coefﬁcients (DC) for
all possible pairwise comparisons.
Results:We found a strong correlation betweenmanual and automated lesion segmentation based on LGA SPM8,
regarding lesion volume (ICC=0.958 andDC=0.60) thatwas not statistically different from the inter-rater cor-
relation (ICC = 0.97 and DC = 0.66). Correlation between the two other algorithms (LGA SPM12 and LPA
SPM12) and manual raters was weaker but still adequate (ICC = 0.927 and DC = 0.53 for LGA SPM12 and
ICC= 0.949 and DC= 0.57 for LPA SPM12). Variability of bothmanual and automated segmentation was signif-
icantly higher regarding lesion numbers.
Conclusion: Automated lesion volume quantiﬁcation can be applied reliably on FLAIR data sets using the SPM
based algorithm of Schmidt et al. and shows good agreement with manual segmentation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Multiple sclerosis (MS) is an inﬂammatory and neurodegenerative
disease of the central nervous system, in which focal and more wide-
spread neuro-axonal loss culminates in neurological disability
(Compston and Coles, 2008). Characteristic changes on magnetic
resonance imaging (MRI) includes (symptomatic and/or asymptomat-
ic) T2 hyperintense or T1 hypointense white matter (WM) lesions;
and, using non-conventional MRI-techniques such as double inversion
recovery (DIR) sequences (Filippi et al., 2012; Miller et al., 2014), focal
hyperintense lesionswithin the greymatter (GM). Over the last two de-
cades, MRI has become key not only for the diagnosis andmonitoring of
MS (Polman et al., 2011) but also as an endpoint for clinical trials, since
T2 lesions next to Gadolinium enhancing T1 lesions are surrogates of
clinical disease activity (Fahrbach et al., 2013; Sormani and Bruzzi,
2013). Against this background, the use of new and newly enlarging
T2-lesions has recently been proposed to substitute relapses, under
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speciﬁc circumstances, as the primary endpoint in phase III clinical MS
trials (Sormani and De Stefano, 2014).
Fluid attenuated inversion recovery (FLAIR) sequences suppress not
only cerebrospinal ﬂuid signal but also blood ﬂow effects and thereby
improve the detection of WM and also GM lesions (Gramsch et al.,
2015), as compared to conventional T2 sequences. T2- and FLAIR lesion
quantiﬁcation, due to methodological constraints, is still largely being
performed manually or in a semi-automated fashion; although both
semi-automated and fully automated quantitative lesion segmentation
approaches have been reported (Ashton et al., 2003; Filippi et al.,
1995; Jain et al., 2015; Shiee et al., 2010; Udupa et al., 1997; Wicks et
al., 1992). Semi-automated methods using seed-based region growing
algorithms (Ashton et al., 2003), fuzzy connectedness (Udupa et al.,
1997), or threshold-based methods (Filippi et al., 1995; Wicks et al.,
1992) may reduce intra-rater variability. Still, they are time consuming
and do not seem suited for large clinical trials. Another limitation of
these methods is the dependency on the rater's input: for example,
manual selection of lesions for seed-based analysis may lead to in-
creased levels of inter-rater variability.
In 2013, Garcia-Lorenzo and colleagues presented an overview of
automated supervised and unsupervised segmentation algorithms
available at that time (Garcia-Lorenzo et al., 2011; Shiee et al., 2010;
Van Leemput et al., 1999) based on which they concluded that a robust,
accurate and fully-automated lesion segmentation tool was still not
available (Garcia-Lorenzo et al., 2013). At the same time, Schmidt and
co-workers (Schmidt et al., 2012) released the lesion segmentation
toolbox (LST) (http://www.applied-statistics.de/lst.htm) which runs
under the Statistical Parametric Mapping (SPM8) software package
(http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm8/). They presented re-
sults from a validation cohort of 52 MS patients and 18 controls with
satisfactory results. In 2015, the same group released an updated ver-
sion of the lesion segmentation toolbox running under the 2014 release
of SPM (SPM12, www.ﬁl.ion.ucl.ac.uk/spm/software/spm12/).
In this study, we aimed to test different versions of LST onMRI scans
from an independentMS patient cohort, acquired on a different scanner
to verify or falsify Schmidt et al.’s results. In addition, we investigated
whether the variability of the LST algorithm (including recent updates)
would be lower than the inter-rater variability of manual segmentation.
This would qualify such an algorithm applicable in clinical practice
without performance loss compared to the gold standard of manual
T2 lesion delineation.
2. Material and methods
2.1. Ethics
The study was approved by the human research and ethics commit-
tee at the University of Sydney, Sydney, Australia. All patients provided
written, informed consent.
2.2. Subjects
MRI data of 50 patients with RRMS (7 males and 43 females with a
mean age of 36.5 years (stdev. 9.0 years) and an average disease dura-
tion of 7.52 years (stdev. 7.01 years)) were randomly selected from a
larger pool of MS patients attending the MS Clinic at the Brain and
Mind Centre, University of Sydney, Australia.
2.3. MRI
AllMRI scanswere acquired on the same 3.0T GE scanner (Discovery
MR750, GE Medical Systems, Milwaukee, WI) using an 8 channel head
coil. A 0.9 mm isotropic 3DT1 (IR-FSPGR, TR/TI/TE = 7.2/2.8/450 ms,
ﬂip angle = 12°) and a 3D CUBE FLAIR (TR/TE/TI = 8000/165/
2179 ms, ﬂip angle =90°, acquisition steps (Freq./Phase) = 256/224,
FOV = 240 mm, slice thickness = 1.2 mm, slice spacing = 0.6 mm)
sequence were acquired. To facilitate manual segmentation of T2
hyper-intense lesions, CUBE FLAIR and 3DT1 were co-registered and
resampled to axial orientation with 2 mm slice thickness. T2 hyperin-
tense contouring was performed on resampled FLAIR images slice by
slice, with references from co-registered T1 images. Binary brain lesion
masks were created automatically after all regions-of-interest were de-
lineated in the brain. The increased slice thickness was justiﬁed based
on results of a pilot study comparingmanual and automated segmenta-
tion on ﬁve original and down sampled data sets. No signiﬁcant differ-
ence could be detected between total lesion volumes of both
reconstructions (The mean lesion volume on these 5 data sets was
5.7 ml; 5.68 ml by manual segmentation, 5.69 ml by automated seg-
mentation on 2 mm slices and 5.83 ml on 0.9 mm slices. The mean vol-
umetric difference between the original and down sampled images was
0.32ml). However, automated segmentationwas performed on original
MRI images.
2.4. Manual and automated segmentation
Three experienced raters (in the following named Hamburg (TK),
Sydney (CW), and Zurich (CE)) manually and independently segment-
ed the full MRI data set. All raters performed axial slice by slice
contouringusingMeVisLab software (MeVis SolutionsAG, Bremen, Ger-
many) in Hamburg and Zurich and manual contouring as implemented
in JIM6.0 (http://www.xinapse.com/) in Sydney. Raters were blinded
regarding the results of the respective other manual raters, as well as
the results of all automated segmentations.
Automated lesion detectionwas performedwith the former and lat-
est lesion segmentation toolbox (LST) (http://www.applied-statistics.
de/lst.htm) published by Schmidt and coworkers (Schmidt et al.,
2012), both running under the SPM software package (http://www.ﬁl.
ion.ucl.ac.uk/spm/). The original LST was developed for the SPM 8 soft-
ware package (http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm8/). In
October 2014, a major update of the SPM software (SPM 12) containing
substantial algorithmic improvements was released. In July 2015, the
Schmidt group released a new version of the LST running under SPM
12 (http://www.ﬁl.ion.ucl.ac.uk/spm/software/spm12) platform. In
this study, we deployed three different automated lesion segmentation
algorithms:
1) Lesion growth algorithmbased on SPM8 (LGA SPM8): this is the orig-
inal algorithm of the ﬁrst release of the LST. The algorithm ﬁrst seg-
ments the T1 image into the main compartments of grey and white
matter and then combines the result with the FLAIR intensities in
order to calculate lesion belief maps. By thresholding these grey mat-
ter lesion believemapswith a pre-chosen initial threshold (kappa), an
initial binary lesion map is obtained which is subsequently grown
along voxels that appear hyperintense in the FLAIR image.
2) Lesion growth algorithms based on SPM12 (LGA SPM12): the main
steps of the LGA algorithms remained unchanged. However, the un-
derlying segmentation of the T1 image was replaced by an SPM12
based algorithm.
3) Lesion prediction algorithms based on SPM12 (LPA SPM12): the up-
dated lesion segmentation toolbox also contains a second complete-
ly and newly developed algorithm, referred to as lesion prediction
algorithm. The LPA requires a FLAIR image only and does not require
the initial thresholding parameter kappa.
We used version 2.0.11 of the updated LST. In the original paper,
Schmidt and colleagues recommend a kappa value of 0.3 as an optimal
default parameter for the LGA (Schmidt et al., 2012). For LGA SPM8 and
LGA SPM12, we also tested kappa values of 0.2 and 0.4.
2.5. Qualitative analysis
All three algorithms generate lesion probability maps as an output
with voxel values between 0 and 1 that were down sampled (using
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tri-linear interpolation) to a 2 mm slice thickness in order to allow a
voxel by voxel comparisonwith themanual lesionmasks.We generated
binary lesion masks for various probability thresholds t by setting all
voxels above that threshold to 1 and to 0 otherwise. Using a connected
component analysis (Thurfjell et al., 1992) we decomposed the
resulting binary lesion maps into connected components representing
separate lesions. Further, we removed lesion clusters containing b8
voxels (=2.56 mm3) from the binary lesion map, because lesions
below that size are not well deﬁned and are very likely to be false pos-
itive ﬁndings of the algorithm. The threshold was chosen based on the
smallest lesion size consistently detected by all three manual raters
(3.2 mm3). We deﬁned the threshold of 2.56mm3 based on a conserva-
tive approach (80% of the smallest consistently detected lesion in our
cohort), which is still less than the minimal lesion size suggested to de-
ﬁne a new or enlarging lesion in a recent publication by Rovira et al.
(Rovira et al., 2010). In the next step, we calculated the total lesion vol-
ume as well as the number of lesions for all 50 data sets. We compared
three differentmeasureswith respect to the lesionsmasks generated by
the three raters to the results of the automated algorithms: the absolute
volume difference (inml), the absolute difference in lesion number, and
the dice coefﬁcient (DC), which measures the degree of overlap be-
tween two binary lesion maps (Dice, 1945). More precisely, if A and B
were two binary lesion masks, then the DC would be deﬁned as 2
 jA∩BjjAjþjBj. We calculated these matrices for all the three rater pairs and
used the mean of the three values (in the following called “raters”) to
simplify the comparison between raters and the results of the automat-
ed algorithms. Additionally, we also calculated sensitivity (jA∩BjjAj , if A is
considered as the ground truth) and false positive rate (B−jA∩BjjBj ) for all
manual rater pairings (six values since each rater was taken as ground
truth) and manual rater – algorithm pairings (only manual raters
were taken as ground truth). To characterize the dependency of the de-
ployed metrics on absolute lesion volumes, we performed the analysis
for the whole cohort as well as for three subgroups with different levels
of total lesion load. As suggested in a recent lesion segmentation valida-
tion study by Jain et al., 2015, we considered a subgroup of patientswith
a total lesion volume b 5 ml as low, between 5 and 15 ml as medium,
and a lesion volume N 15 ml as high lesion load (Jain et al., 2015).
2.6. Statistical analysis
The total lesion volume and lesion number between different raters
and algorithms was compared by means of intra-class correlation coef-
ﬁcients (ICC) (Koch, 1982), calculated using the psy package in R, and
Bland-Altman analyses. Since ICCs are generally meaningful in case of
normally distributed data and T2 lesion volumes are usually skewed,
logarithmic values of all lesion volumeswere calculated before entering
the ICC and Bland-Altman analyses (Adams et al., 1999; Gasperini et al.,
2001). Todeterminewhether the variability betweeneach rater differed
from the variability between the raters and the algorithms,we deployed
an unpaired Student's t-test to compare the DC between each rater with
theDC between the raters and the algorithm. Since absolute volume dif-
ferences and absolute differences in lesion numbers are not normally
distributed, the Wilcoxon rank-sum test was used for comparisons.
The Bland-Altman and ICC analyses were performed with the statistical
software package R (version 3.2.0). All other testswere performed using
the MATLAB 2014a Statistics and Machine Learning Toolbox.
3. Results
MRI scans showed a broad range of total FLAIR lesion volumewith a
median lesion volume (average of three independent raters) of 4.82ml,
with a minimum of 0.20 ml and maximum of 48.97 ml. For some of the
following analyses, patients have been split put into three groups: Low
lesion load (b5ml, n= 26), medium lesion load (5-15ml, n= 14), and
high lesion load (N15 ml, n = 10).
3.1. Dice coefﬁcients
To determine the accuracy of manual raters as well as automated le-
sion segmentation tools, we calculated DC for several lesion map com-
parisons. Fig. 1 shows the mean DC (across all 50 data sets) between
raters and segmentation algorithms depending on a probability thresh-
old t (t=0–0.8) and kappa (0.2, 0.3, and 0.4) for LGA SPM8/SPM12 and
LPA SPM12. The recommended default kappa value (k= 0.3) (Schmidt
et al., 2012) delivered not only higher but also more stable DCs com-
pared to k = 0.2 and k= 0.4 (Fig. 1) and was therefore used for all fur-
ther comparisons. While LGA SPM12 and SPM8were less susceptible to
a threshold change, LPA showed an increased DC with higher thresh-
olds. We found a probability threshold of 0.5 to deliver maximal DCs
and therefore to be optimal for LPA, and t= 0.4 to be optimal for both
LGA algorithms. These probability thresholds were used for all further
analyses.
Table 1 summarizes means and standard deviations of all DCs be-
tween different lesion masks. The DCs for LGA SPM12 (0.53) and LPA
SPM12 (0.57) comparisons with the average of all raters were signiﬁ-
cantly (p = 0.05) lower than the DCs between manual raters (0.66),
whereas LGA SPM8 (DC = 0.60) showed no signiﬁcant difference to
manual raters. Notably, the signiﬁcantly weaker performance of LGA
SPM12 and LPA SPM12 appeared only in those groups of patients with
low or medium but not high lesion load. Overall, LGA SPM8 clearly
outperformed LGA SPM12 and LPA SPM12 when assessed by DCs. Inde-
pendently of total lesion volumes, LGA SPM12 delivered the lowest DCs
compared to both manual raters and the remaining automated
algorithms.
3.2. Absolute volume differences and ICC
To investigate how precisely manual raters and automated tools are
able to segment lesion volumes in MS patients, we calculated absolute
volume differences and ICC for several pairs and compared Bland-Alt-
man plots. Table 2 summarizes absolute volume differences [ml] be-
tween different lesion masks. The median absolute volume difference
between the three raters ranged from 0.4ml to 0.75ml. Themedian ab-
solute volumedifferences between themanual raters and the LGA SPM8
(0.68 ml), LGA SPM12 (0.93ml), and LPA SPM12 (0.85ml) was not sig-
niﬁcantly (p= 0.05) higher or lower than differences between manual
raters (0.66 ml). LGA SPM12 and LPA SPM12 showed numerically
higher volume differences (0.93 and 0.86 ml) than LGA SPM8 (0.68)
when compared to the average manual rater.
Fig. 1.Mean dice coefﬁcients (over n= 50 data sets) depending on threshold (0–0.8) and
kappa (0.2, 0.3, and 0.4) for LGA SPM8/SPM12 and LPA SPM12. For each data set and each
algorithm the mean of the dice to the three raters was computed.
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Fig. 2 shows ICC and Bland-Altman plots of all possible manual rater
pairs with an ICC of 0.970 (Fig. 2A). When comparing the Bland-Altman
plots, Sydney and Zurich showed the highest level of agreement (Fig. 2B).
We visualized the comparisons between the three automated seg-
mentation tools and the averagemanual rater in Fig. 3. LGA SPM8 deliv-
ered the highest ICC (0.959) and the narrowest Bland-Altman plot with
values that are comparable to those of manual rating. LPA SPM12 and
LGA SPM12 showed lower ICCs of 0.949 and 0.927, respectively.
The averaged values of sensitivity and false positive rate are present-
ed in Table 3.
3.3. Lesion number differences
Table 4 shows median and 95th percentiles of absolute lesion num-
ber differences. Manual raters showed a median difference in lesion
numbers of 5.5–8.0 (mean = 8.0) with 95th percentiles of 20.0–52.0
(mean = 40). The performance of LGA SPM8 was comparable to those
of the three manual raters (8.67 (54.00)) while LGA SPM12 and LPA
SPM12 delivered signiﬁcantly higher values. The calculated ICCs (ﬁg-
ures not shown), with 0.901 for manual raters, 0.743 for LGA SPM8,
0.596 for LGA SPM12, and 0.701 for LPA SPM12, were clearly lower
than the ICCs for lesion volume comparisons. The Bland-Altman plots
indicate that all automated segmentation methods lost precision with
increasing lesion numbers (ﬁgures not shown) and the inter-rater var-
iability of manual segmentation increased.
4. Discussion
Deﬁning and validating a gold standard for automated lesion seg-
mentation in MS would be of utmost relevance, not only regarding the
expected decrease in time needed for manual evaluation but also
regarding the notable reduction of bias when data is analyzed by differ-
ent manual raters. Previous studies have reported improvement in
manual intra- and inter-rater variability with semi-automated segmen-
tation tools (Ashton et al., 2003; Filippi et al., 1995). However, the use of
semi-automated segmentation tools is still time consuming and largely
relies on manual input. The validation of a fully automated, fast, and re-
liable tool, applicable in MS clinical trial settings, therefore appears par-
amount. Our aim was to validate a previously published algorithm of
Schmidt and colleagues and to compare variability of fully automated
versus manual segmentation. Within this comparison, we did not re-
strict our analysis to lesion volumes, but also analyzed the performance
of automated lesion segmentation with respect to lesion numbers.
The default kappa value of 0.3 proved to be optimal in our study.
However, as shown in Fig. 1, the results for different kappa values
were comparable. This supports the assumption that the results pre-
sented here are generalizable and an optimization of such a parameter
might not be essential in a multicenter setting in which different scan-
ners are being used. Non-surprisingly, LGA SPM12 and SPM8were rela-
tively unsusceptible to changes of the probability threshold parameter,
since approximately 90% of all voxels on probability maps feature a
value of 1, as already shown in the original work by Schmidt and co-
workers. However, The LPA SPM12 showed higher DCs with higher
thresholds (Fig. 1). The DC reached a maximum value for t = 0.5 and
then decreased again for t values N 0.5. It remains unclear whether a t-
value of 0.5would also result in optimal DC ifMRI imageswere acquired
on different MRI scanners.
4.1. Dice coefﬁcient – accuracy of manual raters and automated tools
When assessed by DC the former SPM8 algorithm clearly
outperformed themore recent SPM12 based algorithms. This might ap-
pear surprising since users of the LST would expect better performance
in the updated version of the toolbox. Numerically, manual raters
reached a slightly higher level of agreement between each other as
compared to the LGA SPM8 algorithm. However, these differences
were not statistically signiﬁcant. The differences were much smaller in
the group of patients with medium or high lesion load. As reported pre-
viously (Schmidt et al., 2012), we found increasing DCs with increasing
lesion loads. This was the case both for the between-rater comparisons
and for the comparison betweenmanual and automated segmentation.
A possible explanation might be that a disagreement on a single voxel
has a higher impact on overall agreement if the total segmented voxel
number is low. Therefore, one might question whether DCs are an ap-
propriate parameter to describe the accuracy of lesion segmentation
in patients with a very low lesion load.
Previous studies (Jain et al., 2015) reported DCs in a similar range
compared to our study (0.55 for LGA SPM 8, 0.67 for MSmetrix, and
0.61 for Lesion TOADS). As opposed to the study by Jain et al., N50% of
patients in our study had a lesion load below 5 ml whereas in their
study only 15% of patients (3/20) had similarly low lesion volumes.
Against this background, the DC presented in our study might even be
underestimated in comparison to the study by Jain et al. due to the
high number of patients with very low lesion loads.
4.2. Absolute volume differences and ICC - precision of manual raters and
automated tools
LGA SPM8 clearly outperformed the new SPM12 based LGA and LPA
algorithms for determination of lesion volumes. Both, LGA SPM12 and
LPA SPM12 showed signiﬁcantly higher volume differences to manual
raters than LGA SPM8.
The between-rater variability in assessing total lesion volumes (range
0.40–0.75, median 0.66ml) was as high as between raters and LGA SPM8
(0.68). Therefore, the assessment of total lesion volume bymanual rating
and automated detection with LGA SPM8 appears interchangeable. The
fact that LGA SPM8 showed ICCs, false positive rates, and absolute volume
Table 1
Mean and standard deviation of dice coefﬁcients (DC).
All
(n = 50)
b5 ml
(n = 26)
5–15 ml
(n = 14)
N15 ml
(n = 10)
Ham-Syd 0.67 (0.12) 0.63 (0.15) 0.69 (0.06) 0.74 (0.08)
Ham-Zur 0.66 (0.13) 0.61 (0.16) 0.68 (0.06) 0.74 (0.07)
Zur-Syd 0.67 (0.12) 0.63 (0.14) 0.69 (0.07) 0.72 (0.09)
Raters 0.66 (0.12) 0.62 (0.14) 0.69 (0.06) 0.73 (0.08)
Raters-LGA SPM 8 0.60 (0.15) 0.53 (0.16) 0.65 (0.08) 0.70 (0.09)
Raters-LGA SPM 12 0.53* (0.16) 0.45* (0.18) 0.59* (0.09) 0.63 (0.10)
Raters-LPA 0.57* (0.16) 0.49* (0.17) 0.63 (0.10) 0.68 (0.11)
Means and standard deviations (in brackets) of DC between lesion masks generated by
manual or automated segmentation. The numbers marked with an asterisk indicate DC
which are signiﬁcantly (p = 0.05) different from the DC of the manual raters ("Raters").
In columns 3–5 the same analysis was performed but restricted to groups with different
total lesion volumes.
Table 2
Median and 95th percentiles of absolute volume differences in ml.
All
(n = 50)
b5 ml
(n = 26)
5–15 ml
(n = 14)
N15 ml
(n = 10)
Ham-Syd 0.64 (5.45) 0.27 (2.57) 0.86 (3.82) 3.75 (16.94)
Ham-Zur 0.75 (3.13) 0.47 (2.12) 1.02 (3.70) 1.65 (3.29)
Zur-Syd 0.40 (4.49) 0.28 (1.25) 0.39 (3.13) 1.97 (15.61)
Raters 0.66 (3.63) 0.39 (1.85) 0.76 (2.71) 2.63 (11.29)
Raters-LGA SPM 8 0.68 (7.13) 0.38 (3.14) 0.93 (3.75) 2.94 (9.53)
Raters-LGA SPM 12 0.93 (7.61) 0.47 (3.67) 1.55 (5.16) 5.56 (16.15)
Raters-LPA 0.85 (8.13) 0.49 (2.27) 1.40 (5.05) 3.77 (16.58)
Medians and 95th percentiles (in brackets) of absolute volume difference inml. The num-
bers marked with an asterisk indicate values which are signiﬁcantly (p = 0.05) different
from the between differences of the manual raters ("Raters"). In columns 3–5 the same
analysis was performed but restricted to groups with different levels of total lesion
volume.
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differences close to the inter-rater comparison supports our observation,
whereas the sensitivity readouts suggest that LGA SPM8 might perform
a more conservative segmentation than manual raters. Interestingly, the
absolute volume differences we received in our study were higher than
those reported in the study by Jain et al. in 2015 (mean 4.75 ml + −
3.63) (Jain et al., 2015), whereas ICCs in our study (0.927–0.958) were
higher than in the Jain paper (0.63–0.80) (Jain et al., 2015). The Pearson's
squared correlation coefﬁcient between manual raters and LGA SPM8
(R2=0.94) was comparable to the value reported by Schmidt et al.
(R2=0.93) (Schmidt et al., 2012).
In multicenter MS clinical trials, as much as in routine clinical prac-
tice, MRI T2/FLAIR lesion load is assessed longitudinally. It is against
this background thatmeasures of inter-rater variability in T2 lesion seg-
mentation are crucial to understand the intrinsic variability of themeth-
odology used for segmentation. The 95th percentile of the absolute
volume differences between manual raters in our study showed a
range from 3.13 to 5.45 ml (mean 3.63 ml); a minimum volume differ-
ence in total lesion load detectable in longitudinal or cross-sectional
studies with an error probability of 5% can therefore be estimated to
be in the range of 3.60 ml.
In longitudinal studies the level of variability can be reduced signif-
icantly when two scans are assessed simultaneously using co-registra-
tion/subtraction approaches as has been suggested by others
(Battaglini et al., 2014; Moraal et al., 2010).
4.3. Lesion number differences – lack of precision bymanual and automated
segmentation
Quantiﬁcation of lesion numbers by both manual and automated
segmentation performed worse than lesion volume quantiﬁcation.
Even if two manual raters showed a high agreement, comparison to
the third rater underlines the variability of manual segmentation,
which is comparable to the disagreement between algorithms and aver-
age manual performance. Again, LGA SPM8 showed values close to
manual segmentation, while SPM12 based LGA and LPA showed signif-
icantly higher lesion number differences.
Of interest, all algorithms underestimated total lesion numbers in
patients with a high lesion load (ﬁgures not shown). This might be ex-
plained by the difﬁculties in assessing conﬂuent lesions, e.g. in the
periventricular area.
5. Conclusion
In this study, we investigated the inter-rater variability of manual
versus automated MRI FLAIR lesion segmentation in a set of MRI scans
from 50 patients with MS. We further analyzed whether the variability
of the LST algorithm published by Schmidt et al. (including recent up-
dates) is smaller than the inter-rater variability of manual segmenta-
tion. We estimated the inter-rater variability of measuring total lesion
load in FLAIR images to be 3.63 ml accepting an error probability of 5%.
LGA SPM8 shows variabilities for measuring volumetric lesion load
and lesion number, which are comparable to the inter-rater variabilities.
This qualiﬁes LGA SPM8 to be used for volumetric lesion segmentation
in clinical applications without performance loss compared to manual
lesion volume segmentation when applied on FLAIR images.
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Table 3
Sensitivity and false positive rate.
Sensitivity False positive rate
Manual rater 0.676 0.324
LPA SPM12 0.628 0.457
LGA SPM8 0.566 0.335
LGA SPM12 0.505 0.393
Averaged sensitivity and false positive rate of all six possiblemanual rater pairings (“Man-
ual rater”; each rater was taken as ground truth for each comparison) and algorithm-to-
rater comparison (only manual rater were taken as ground truth).
Table 4
Median and 95th percentiles of absolute differences in lesion
numbers.
All (n = 50)
Ham-Syd 8.00 (49.00)
Ham-Zur 5.50 (20.00)
Zur-Syd 6.00 (52.00)
Raters 8.00 (40.00)
Raters-LGA SPM 8 8.67 (54.00)
Raters-LGA SPM 12 10.50* (63.00)
Raters-LPA 16.83* (45.67)
Median and 95th percentiles (in brackets) of absolute differences in
lesion numbers. The numbers marked with an asterisk indicate the
values which are signiﬁcantly (p = 0.05) different from the differ-
ences between the manual raters ("Raters").
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